Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Completed 6Recruiting 4Unknown 3Terminated 2Not yet recruiting 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 4

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 429Breast Neoplasms 298Neoplasms 296Colorectal Neoplasms 242Neoplasm Metastasis 197Ovarian Neoplasms 171Lung Neoplasms 150Recurrence 147Prostatic Neoplasms 146Pancreatic Neoplasms 142Multiple Myeloma 136Stomach Neoplasms 129Squamous Cell Carcinoma of Head and Neck 128Melanoma 123Leukemia, Myeloid, Acute 115Endometrial Neoplasms 115Advanced Solid Tumors 113Advanced Solid Tumor 108Carcinoma, Hepatocellular 102Triple Negative Breast Neoplasms 101Small Cell Lung Carcinoma 88Uterine Cervical Neoplasms 86Lymphoma, Non-Hodgkin 83Carcinoma, Renal Cell 72Lymphoma, Follicular 71Lymphoma 67Leukemia, Lymphocytic, Chronic, B-Cell 65Solid Tumor 64Lymphoma, Large B-Cell, Diffuse 64Hematologic Neoplasms 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × INDUSTRY × Advanced Tumors × Clear all
NCT06245122 2026-04-06

A Study of CS23546 in Subjects With Advanced Tumors

Chipscreen Biosciences, Ltd.

Phase 1 Recruiting
156 enrolled

Advanced Tumors

NCT07110584 2026-03-05

Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors

ModeX Therapeutics, An OPKO Health Company

Phase 1/2 Recruiting
235 enrolled

Advanced Tumors

NCT07205198 2026-01-08

A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.

Shanghai Institute Of Biological Products

Phase 1 Recruiting
160 enrolled

Advanced Tumors

NCT07179081 2025-09-17

A Study of AL58805 in Patients With Advanced Tumors

Advenchen Laboratories, LLC

Phase 1 Recruiting
40 enrolled

Advanced Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡